Mitotane With or Without Cisplatin and Etoposide for Patients with a High Risk of Recurrence in Stages 1–3 Adrenocortical Cancer After Surgery

Amber Leila Sarvestani; Stephanie N. Gregory; Martha E. Teke; Massimo Terzolo; Alfredo Berruti; Jonathan M. Hernandez; Mouhammed Amir Habra

doi:10.1245/s10434-022-12725-4

Mitotane With or Without Cisplatin and Etoposide for Patients with a High Risk of Recurrence in Stages 1–3 Adrenocortical Cancer After Surgery

Amber Leila Sarvestani, Stephanie N. Gregory, Martha E. Teke, Massimo Terzolo, Alfredo Berruti, Jonathan M. Hernandez, Mouhammed Amir Habra

Endocrine Neoplasia & HD

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	680-682
Number of pages	3
Journal	Annals of surgical oncology
Volume	30
Issue number	2
DOIs	https://doi.org/10.1245/s10434-022-12725-4
State	Published - Feb 2023

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1245/s10434-022-12725-4

Cite this

@article{0efd3ec1738d44279d192c622fc765cb,

title = "Mitotane With or Without Cisplatin and Etoposide for Patients with a High Risk of Recurrence in Stages 1–3 Adrenocortical Cancer After Surgery",

author = "Sarvestani, {Amber Leila} and Gregory, {Stephanie N.} and Teke, {Martha E.} and Massimo Terzolo and Alfredo Berruti and Hernandez, {Jonathan M.} and Habra, {Mouhammed Amir}",

year = "2023",

month = feb,

doi = "10.1245/s10434-022-12725-4",

language = "English (US)",

volume = "30",

pages = "680--682",

journal = "Annals of surgical oncology",

issn = "1068-9265",

publisher = "Springer New York",

number = "2",

}

TY - JOUR

T1 - Mitotane With or Without Cisplatin and Etoposide for Patients with a High Risk of Recurrence in Stages 1–3 Adrenocortical Cancer After Surgery

AU - Sarvestani, Amber Leila

AU - Gregory, Stephanie N.

AU - Teke, Martha E.

AU - Terzolo, Massimo

AU - Berruti, Alfredo

AU - Hernandez, Jonathan M.

AU - Habra, Mouhammed Amir

PY - 2023/2

Y1 - 2023/2

UR - http://www.scopus.com/inward/record.url?scp=85140967273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85140967273&partnerID=8YFLogxK

U2 - 10.1245/s10434-022-12725-4

DO - 10.1245/s10434-022-12725-4

M3 - Comment/debate

C2 - 36305989

AN - SCOPUS:85140967273

SN - 1068-9265

VL - 30

SP - 680

EP - 682

JO - Annals of surgical oncology

JF - Annals of surgical oncology

IS - 2

ER -

Mitotane With or Without Cisplatin and Etoposide for Patients with a High Risk of Recurrence in Stages 1–3 Adrenocortical Cancer After Surgery

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this